bullish

Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?

We believe that perfusion technology from Miromatrix differentiates from 3D bioprinting and genetically modified xenografts and has more advantages to develop high-quality bioengineered organs
284 Views08 Jul 2021 01:55
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Analytics & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
Logo
Rising
Andrei Zakharov
Covering IPOs, Healthcare and Technology Stocks
Information Technology & EnergyEquitiesEquity Capital MarketsThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?
    08 Jul 2021
x